The application of proton pump inhibitors in cardiovascular disease needs to be individualized

Affiliations

¹ Department of Gastroenterology, Liaocheng People's Hospital Affiliated to Graduate School of Shandong First Medical University, Liaocheng, Shandong Province, People's Republic of China.
² Department of Cardiology, Liaocheng People's Hospital Affiliated to Graduate School of Shandong First Medical University, Liaocheng, Shandong Province, People's Republic of China.
³ Department of Cardiology, Liaocheng People's Hospital Affiliated to Graduate School of Shandong First Medical University, Liaocheng, Shandong Province, People's Republic of China. 1285296769@qq.com.

Comment

Xi-Liang Wang et al. Cardiovasc Drugs Ther. 2022 Dec.

. 2022 Dec;36(6):1247-1248.

doi: 10.1007/s10557-022-07395-z. Epub 2022 Oct 22.

¹ Department of Gastroenterology, Liaocheng People's Hospital Affiliated to Graduate School of Shandong First Medical University, Liaocheng, Shandong Province, People's Republic of China.
² Department of Cardiology, Liaocheng People's Hospital Affiliated to Graduate School of Shandong First Medical University, Liaocheng, Shandong Province, People's Republic of China.
³ Department of Cardiology, Liaocheng People's Hospital Affiliated to Graduate School of Shandong First Medical University, Liaocheng, Shandong Province, People's Republic of China. 1285296769@qq.com.

No abstract available

Comment on

Proton Pump Inhibitor and Clopidogrel Use After Percutaneous Coronary Intervention and Risk of Major Cardiovascular Events.
Maret-Ouda J, Santoni G, Xie S, Rosengren A, Lagergren J. Maret-Ouda J, et al. Cardiovasc Drugs Ther. 2022 Dec;36(6):1121-1128. doi: 10.1007/s10557-021-07219-6. Epub 2021 Jul 9. Cardiovasc Drugs Ther. 2022. PMID: 34241731 Free PMC article.

1. Maret-Ouda J, Santoni G, Xie S, Rosengren A, Lagergren J. Proton pump inhibitor and clopidogrel use after percutaneous coronary intervention and risk of major cardiovascular rvents. Cardiovasc Drugs Ther. 2021. https://doi.org/10.1007/s10557-021-07219-6 .
1. Evanchan J, Donnally MR, Binkley P, Mazzaferri E. Recurrence of acute myocardial infarction in patients discharged on clopidogrel and a proton pump inhibitor after stent placement for acute myocardial infarction. Clin Cardiol. 2010;33(3):168–71. - DOI - PubMed - PMC
1. Shi WC, Gao SD, Yang JG et al. Impact of proton pump inhibitors on clinical outcomes in patients after acute myocardial infarction: a propensity score analysis from China Acute Myocardial Infarction (CAMI) registry. J Geriatr Cardiol. 2020;17(11):659–65. - PubMed - PMC
1. Xie J, Chen Q, He D. Pre-existing Proton Pump Inhibitor Treatment and Short-Term Prognosis of Acute Myocardial Infarction Patients. Front Cardiovasc Med. 2022;9:919716. - DOI - PubMed - PMC
1. Khawaja M, Thakker J, Kherallah R et al. Antacid therapy in coronary artery disease and heart failure: proton pump inhibitors vs. H2 receptor blockers. Cardiovasc Drugs Ther. 2022. https://doi.org/10.1007/s10557-022-07358-4 .